Business Wire
BusinessFTC issues civil subpoenas to OpenAI and Anthropic in consumer-protection probe, spotlighting regulatory risk for Microsoft and other major AI backersThe Apex TimesBusinessSkydance steadies after merger-era drop, Disney firms and Netflix eases lower in afternoon tradingThe Apex TimesBusinessBlackRock files a bitcoin ETF structure aimed at limiting losses and capping gains using optionsThe Apex TimesBusinessModerna shares jump 7% as melanoma vaccine data in Madrid draws attention; Bristol Myers and Pfizer also edge higherThe Apex TimesBusinessChevron seeks stake shift in Iraq oil field tied to Russian influence, as U.S. pressures the status quoThe Apex TimesBusinessCaterpillar vs. Deere in the data-center buildout debate: what investors are weighingThe Apex TimesBusinessBraze shares surge after Salesforce agrees to buy the marketing software company for $47The Apex TimesBusinessAlaska Airlines names CVS Health executive for newly created technology and AI roleThe Apex TimesBusinessEli Lilly’s pediatric ulcerative colitis trial results put Omvoh back in focus for investors, but full details remain limitedThe Apex TimesBusinessGeneral Motors shares fall about 6% even after a reported earnings beat, as investors focus on the narrower outlook rangeThe Apex TimesBusinessWalmart ties Walmart+ and Sam’s Club into a single $120-a-year membership bundleThe Apex TimesBusinessBoeing and Microsoft collaboration on an AI “dataliner” platform draws analyst attention, lifting BMO’s Microsoft targetThe Apex TimesBusinessFTC issues civil subpoenas to OpenAI and Anthropic in consumer-protection probe, spotlighting regulatory risk for Microsoft and other major AI backersThe Apex TimesBusinessSkydance steadies after merger-era drop, Disney firms and Netflix eases lower in afternoon tradingThe Apex TimesBusinessBlackRock files a bitcoin ETF structure aimed at limiting losses and capping gains using optionsThe Apex TimesBusinessModerna shares jump 7% as melanoma vaccine data in Madrid draws attention; Bristol Myers and Pfizer also edge higherThe Apex TimesBusinessChevron seeks stake shift in Iraq oil field tied to Russian influence, as U.S. pressures the status quoThe Apex TimesBusinessCaterpillar vs. Deere in the data-center buildout debate: what investors are weighingThe Apex TimesBusinessBraze shares surge after Salesforce agrees to buy the marketing software company for $47The Apex TimesBusinessAlaska Airlines names CVS Health executive for newly created technology and AI roleThe Apex TimesBusinessEli Lilly’s pediatric ulcerative colitis trial results put Omvoh back in focus for investors, but full details remain limitedThe Apex TimesBusinessGeneral Motors shares fall about 6% even after a reported earnings beat, as investors focus on the narrower outlook rangeThe Apex TimesBusinessWalmart ties Walmart+ and Sam’s Club into a single $120-a-year membership bundleThe Apex TimesBusinessBoeing and Microsoft collaboration on an AI “dataliner” platform draws analyst attention, lifting BMO’s Microsoft targetThe Apex TimesBusinessFTC issues civil subpoenas to OpenAI and Anthropic in consumer-protection probe, spotlighting regulatory risk for Microsoft and other major AI backersThe Apex TimesBusinessSkydance steadies after merger-era drop, Disney firms and Netflix eases lower in afternoon tradingThe Apex TimesBusinessBlackRock files a bitcoin ETF structure aimed at limiting losses and capping gains using optionsThe Apex TimesBusinessModerna shares jump 7% as melanoma vaccine data in Madrid draws attention; Bristol Myers and Pfizer also edge higherThe Apex TimesBusinessChevron seeks stake shift in Iraq oil field tied to Russian influence, as U.S. pressures the status quoThe Apex TimesBusinessCaterpillar vs. Deere in the data-center buildout debate: what investors are weighingThe Apex TimesBusinessBraze shares surge after Salesforce agrees to buy the marketing software company for $47The Apex TimesBusinessAlaska Airlines names CVS Health executive for newly created technology and AI roleThe Apex TimesBusinessEli Lilly’s pediatric ulcerative colitis trial results put Omvoh back in focus for investors, but full details remain limitedThe Apex TimesBusinessGeneral Motors shares fall about 6% even after a reported earnings beat, as investors focus on the narrower outlook rangeThe Apex TimesBusinessWalmart ties Walmart+ and Sam’s Club into a single $120-a-year membership bundleThe Apex TimesBusinessBoeing and Microsoft collaboration on an AI “dataliner” platform draws analyst attention, lifting BMO’s Microsoft targetThe Apex TimesBusinessFTC issues civil subpoenas to OpenAI and Anthropic in consumer-protection probe, spotlighting regulatory risk for Microsoft and other major AI backersThe Apex TimesBusinessSkydance steadies after merger-era drop, Disney firms and Netflix eases lower in afternoon tradingThe Apex TimesBusinessBlackRock files a bitcoin ETF structure aimed at limiting losses and capping gains using optionsThe Apex TimesBusinessModerna shares jump 7% as melanoma vaccine data in Madrid draws attention; Bristol Myers and Pfizer also edge higherThe Apex TimesBusinessChevron seeks stake shift in Iraq oil field tied to Russian influence, as U.S. pressures the status quoThe Apex TimesBusinessCaterpillar vs. Deere in the data-center buildout debate: what investors are weighingThe Apex TimesBusinessBraze shares surge after Salesforce agrees to buy the marketing software company for $47The Apex TimesBusinessAlaska Airlines names CVS Health executive for newly created technology and AI roleThe Apex TimesBusinessEli Lilly’s pediatric ulcerative colitis trial results put Omvoh back in focus for investors, but full details remain limitedThe Apex TimesBusinessGeneral Motors shares fall about 6% even after a reported earnings beat, as investors focus on the narrower outlook rangeThe Apex TimesBusinessWalmart ties Walmart+ and Sam’s Club into a single $120-a-year membership bundleThe Apex TimesBusinessBoeing and Microsoft collaboration on an AI “dataliner” platform draws analyst attention, lifting BMO’s Microsoft targetThe Apex Times
Back to front
Berkshire Hathaway’s concentrated bet: one stock accounts for about 20% of Buffett’s $341 billion portfolio, a new report says
The Apex Times

THE APEX TIMES

Business/The Apex Times/Jun 20, 1:35 PM EDT

Berkshire Hathaway’s concentrated bet: one stock accounts for about 20% of Buffett’s $341 billion portfolio, a new report says

A market-focused analysis says Warren Buffett-led Berkshire Hathaway holds a single position worth roughly one-fifth of its $341 billion equity portfolio, pointing to the company’s growing exposure to the AI boom.

Berkshire Hathaway, the Warren Buffett-led conglomerate whose investments are closely watched for clues about long-term market views, is facing fresh scrutiny for how concentrated its biggest stock holding has become. A Yahoo Finance report published June 20 says roughly 20% of Berkshire’s $341 billion portfolio is invested in one stock that the piece describes as “quietly trying to cash in on the AI boom.”

The report also characterizes that holding as a major market winner over time, saying the stock’s share price has risen more than 12-fold over the past decade. That kind of run matters in the Berkshire context because it implies the position has likely grown through a mix of operating performance and stock-market re-pricing, even as Berkshire is typically associated with a slower, valuation-driven approach.

Still, the specific stock name is not included in the material provided for this editorial draft, so this story cannot confirm the identity of the holding or the exact timing and cost basis of the position from the information at hand. What is clear from the report’s framing is the magnitude of the concentration: one position is large enough that small changes in that company’s outlook would have outsized effects on Berkshire’s overall equity portfolio.

Berkshire Hathaway does not run a business built around trading activity. It holds operating companies and invests in public equities, and its portfolio is commonly used as a barometer for how its managers see risk and opportunity. A single stock representing about one-fifth of the portfolio, as the report claims, shifts the focus from diversification to conviction, especially when the narrative ties the position to AI-related demand.

The report’s “AI boom” framing suggests the stock’s business model or customer exposure is tied to technologies and spending themes associated with artificial intelligence. In practical terms, that means investors are watching not only whether the company grows, but whether it can capture AI-driven infrastructure and software demand that is currently reshaping enterprise spending priorities.

Even for a company as large as Berkshire Hathaway, concentration introduces a different type of uncertainty. If AI-linked demand slows, if competition intensifies, or if the stock’s valuation changes, the effects would likely be felt more directly than they would be in a more evenly distributed portfolio.

Berkshire Hathaway’s disclosures and filings would normally be the authoritative source for confirming the holding size, percentage of the portfolio, and which stock accounts for it. In this draft, those details cannot be verified beyond the figures stated in the Yahoo Finance item.

Going forward, investors will likely look for Berkshire’s next round of portfolio updates and for any company-specific reporting that clarifies how the AI theme translates into revenue, margins, and cash flow. The immediate watch point is whether the underlying business remains on track to justify a position that, according to the report, is large enough to represent a significant share of the portfolio’s value.

Why It Matters

  • Concentration risk is elevated when one position represents a large share of a portfolio, making Berkshire’s equity performance more sensitive to a single company’s results and valuation.
  • AI-linked investment narratives can accelerate stock performance, but they also invite sharper swings if expectations for AI demand change.
  • Because Berkshire’s investments are followed as a announcement of conviction, updates that preserve or increase concentration may influence how investors interpret Berkshire’s longer-term strategy.
  • If the holding is indeed tied to AI infrastructure or software spending, it would highlight how even traditionally diversified conglomerates are increasingly exposed to technology-driven growth themes.

Sources

Key Facts

  • A Yahoo Finance report dated June 20 says Warren Buffett-led Berkshire Hathaway has a $341 billion portfolio and that about 20% of it is invested in one stock.
  • The same report describes that stock as seeking to benefit from the AI boom.
  • The report states the stock’s share price has risen more than 12-fold over the past decade.
  • Berkshire Hathaway’s stock is identified here as BRK.B (NYSE:BRK.B).
  • The specific name of the stock and the exact portfolio mechanics (for example, whether the 20% is based on market value, reported cost, or a specific classification) are not present in the provided material for this draft.

Finance Related

Oct 20, 1:14 PM EDT
The Apex Times

JPMorgan weighs the value of physical branches as banks compete for higher-value customers

A new stock-market analysis highlights JPMorgan Chase’s continued branch expansion, arguing that in-person presence can help win and retain customers who generate deposits, investment revenue, and loan demand. But the company has not provided detailed, publicly disclosed results tying specific branch openings to profitability or customer retention.

JPMorgan weighs the value of physical branches as banks compete for higher-value customers
The Apex Times
Berkshire Hathaway’s concentrated bet: one stock accounts for about 20% of Buffett’s $341 billion portfolio, a new report says | The Apex Times